proteasome inhibitors (Novartis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameproteasome inhibitors (Novartis)
Drug Alias NameNVP-AFB340NVP-AFD314NVP-AEC667
ClassificationSmall molecules
Mechanisms of ActionProteasome inhibitorsApoptosis stimulantsCell cycle inhibitors
TargetsProteasome
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A